Association of the programmed cell death-1 PD1.5 C>T polymorphism with cervical cancer risk in a Chinese population

被引:9
作者
Li, X. F. [1 ]
Jiang, X. Q. [2 ]
Zhang, J. W. [3 ]
Jia, Y. J. [1 ]
机构
[1] Weifang Tradit Chinese Hosp, Dept Gynecol, Wei Fang, Peoples R China
[2] Weifang Matern & Child Care Hosp, Dept Obstet & Gynecol, Wei Fang, Peoples R China
[3] Hanting Dist Peoples Hosp Weifang, Dept Obstet & Gynecol, Wei Fang, Peoples R China
关键词
Programmed death 1; Single nucleotide polymorphism; Cervical cancer; Incidence; Case-control study; BREAST-CANCER; PD-1; B7-H1; GENE; SUSCEPTIBILITY; CARCINOMA; MECHANISM; LIGAND;
D O I
10.4238/gmr.15016357
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The association of the programmed cell death-1 PD1.5 C > T polymorphism with cervical cancer risk has not been investigated. In this hospital-based case-control study, we analyzed 256 patients with cervical cancer and 250 healthy controls. Pearson chi-square test was used to examine differences in the distribution of genotypes between cases and controls. Association between the polymorphism and the susceptibility to cervical cancer was evaluated using unconditional logistic regression analysis. This revealed that the frequencies of the three genotypes (CC, CT, and TT) in cervical cancer cases and controls were 17.58, 65.23, and 17.19% and 24.80, 40.40, and 34.80%, respectively; the difference between the two groups was significant (P < 0.001). We found that the CT genotype was significantly associated with increased cervical cancer risk (adjusted OR = 2.18; 95% CI = 1.37-6.11; P = 0.009). Moreover, there was significant association between PD-1.5 C/T polymorphism and susceptibility to cervical cancer under dominant model (OR = 1.27, 95% CI = 1.01-2.15, P = 0.047). We conclude that the PD-1.5 C/T polymorphism may be associated with increased risk of cervical cancer. The study also highlights the importance of conducting genetic association studies in different ethnic populations.
引用
收藏
页数:7
相关论文
共 25 条
[1]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[2]   Genetic, Immunologic, and Immunohistochemical Analysis of the Programmed Death 1/Programmed Death Ligand 1 Pathway in Human Systemic Lupus Erythematosus [J].
Bertsias, George K. ;
Nakou, Magda ;
Choulaki, Christlanna ;
Raptopoulou, Amalia ;
Papadimitraki, Eva ;
Goulielmos, George ;
Kritikos, Herakles ;
Sidiropoulos, Prodromos ;
Tzardi, Maria ;
Kardassis, Dimitris ;
Mamalaki, Clio ;
Boumpas, Dimitrios T. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (01) :207-218
[3]   Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy [J].
Blank, C ;
Gajewski, TF ;
Mackensen, A .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (04) :307-314
[4]  
Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
[5]   Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix [J].
Ferguson, Rhea ;
Ramanakumar, Agnihotram V. ;
Koushik, Anita ;
Coutlee, Francois ;
Franco, Eduardo ;
Roger, Michel .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (03) :E312-E319
[6]  
Franceschi S, 2005, RECENT RESULTS CANC, V166, P277
[7]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[8]   The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: Correlation with important high-risk prognostic factors [J].
Ghebeh, Hazem ;
Mohammed, Shamayel ;
Al-Omair, Abeer ;
Qattan, Amal ;
Lehe, Cynthia ;
Al-Qudaihi, Ghofran ;
Elkum, Naser ;
Alshabanah, Mohamed ;
Bin Amer, Suad ;
Tulbah, Asma ;
Ajarim, Dahish ;
Al-Tweigeri, Taher ;
Dermime, Said .
NEOPLASIA, 2006, 8 (03) :190-198
[9]   PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China [J].
Hua, Zhang ;
Li, Dalin ;
Xiang, Gao ;
Xu, Fengyan ;
Jie, Guan ;
Fu, Zhenkun ;
Jie, Zhang ;
Da, Pang ;
Li, Dianjun .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) :195-201
[10]   PD-1 and its ligands in tolerance and immunity [J].
Keir, Mary E. ;
Butte, Manish J. ;
Freeman, Gordon J. ;
Sharpel, Arlene H. .
ANNUAL REVIEW OF IMMUNOLOGY, 2008, 26 :677-704